BioRem Inc. (CVE:BRM – Get Free Report) Director Derek Webb sold 120,000 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of C$2.93, for a total transaction of C$351,600.00.
BioRem Price Performance
BioRem stock opened at C$2.81 on Friday. BioRem Inc. has a 52 week low of C$0.92 and a 52 week high of C$3.39. The company’s 50 day moving average price is C$2.70 and its two-hundred day moving average price is C$2.33. The stock has a market cap of C$44.12 million, a P/E ratio of 13.38 and a beta of 0.85. The company has a quick ratio of 1.08, a current ratio of 1.57 and a debt-to-equity ratio of 48.97.
About BioRem
Recommended Stories
- Five stocks we like better than BioRem
- Roth IRA Calculator: Calculate Your Potential Returns
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.